Found 21 matching trials
A Clinical Trial of Lurasidone in Treatment of Schizophrenia
PHASE3This is a randomized, double-blind, double-dummy, parallel- controlled, adj...
Location
Capital Medical University Affiliated Beijing Anding Hospital
A Study of Lurasidone HCl in Subjects With Schizophrenia
PHASE4The study evaluates the effectiveness and safety of Lurasidone in subjects ...
Location
Taipei City Hospital, Songde Branch
Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
PHASE2The overarching purpose of this pilot study is to collect preliminary data ...
Location
University of North Carolina
A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
PHASE3This is a study designed to evaluate the efficacy and safety of lurasidone ...
Location
Borame Medical Center
Lithium Drug-Drug Interaction Study With Lurasidone HCl
PHASE1The purpose of this study is to evaluate the drug-drug interaction effect b...
Chinese Longitudinal and Systematic Study of Bioplar Disorder
NAAffective disorders (mainly including major depressive disorder and bipolar...
Location
The First Affiliated Hospital of Zhejiang University
Safety and Tolerability Study of Drug to Treat Schizophrenia
PHASE2The purpose of this study is to evaluate the long-term safety of SM-13496 i...
Location
Birmingham Psychiatry Pharmaceutical
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
PHASE4This study is an 8-week open-label trial testing Lurasidone (Latuda®) as a ...
Location
Massachusetts General Hospital
A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia
PHASE2The purpose of this study is to evaluate the efficacy of the drug SM-13496 ...
Location
Birmingham Psychiatry Pharmaceutical
A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia
PHASE2A 6-week in-patient and out-patient study to test the effectiveness and saf...
Location
Birmingham Psychiatry Pharmaceutical